Improving The Patient Experience Without Sacrificing Quality Of Care

Oncology drugs have rapidly evolved, but the delivery technology has not changed as quickly. While intravenous-based (IV) therapies are effective, they require patients to spend hours in an infusion center. In an effort to change how IV- and syringe-based oncology drug treatments are administered, West’s SmartDose® platform is available to expand patient access to SC delivery via a large-volume device that attaches to the patient. This gives the patient more freedom of movement at the center or allows administration to occur at a different location altogether.
VIEW THE ARTICLE!
Log In
Signing up provides unlimited access to:
Free Sign Up

Signing up provides unlimited access to:
- Trend and Leadership Articles
- Case Studies
- Extensive Product Database
- Premium Content
HELLO. PLEASE LOG IN.
X
Not yet a member of Outsourced Pharma? Register today.
ACCOUNT SIGN UP
X
Please fill in your account details
ACCOUNT SIGN UP
West Pharmaceutical Services, Inc.
This website uses cookies to ensure you get the best experience on our website. Learn more